These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 6202917)

  • 1. [Treatment of stage I, II testicular tumor based on tumor markers].
    Kamidono S; Arakawa S; Hamami G; Umezu K; Fujii A; Ishigami J
    Nihon Hinyokika Gakkai Zasshi; 1983 Aug; 74(8):1383-93. PubMed ID: 6202917
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of alpha-fetoprotein and human chorionic gonadotropin in seminoma.
    Javadpour N; McIntire KR; Waldmann TA; Bergman SM
    J Urol; 1978 Dec; 120(6):687-90. PubMed ID: 83391
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of seminoma: does a positive HCG influence prognosis?
    Bartsch G; Mikuz G; Frommhold H; Scheiber K
    Prog Clin Biol Res; 1985; 203():483-4. PubMed ID: 2421340
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum alpha fetoprotein and human chorionic gonadotropin in the diagnosis and management of nonseminomatous germ-cell testicular cancer.
    Lange PH; McIntire KR; Waldmann TA; Hakala TR; Fraley EE
    N Engl J Med; 1976 Nov; 295(22):1237-40. PubMed ID: 62281
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of seminoma.
    Horwich A; Dearnaley DP
    Semin Oncol; 1992 Apr; 19(2):171-80. PubMed ID: 1372759
    [No Abstract]   [Full Text] [Related]  

  • 6. Serial monitoring of serum alpha-fetoprotein and chorionic gonadotropin in males with germ cell tumors.
    Thompson DK; Haddow JE
    Cancer; 1979 May; 43(5):1820-9. PubMed ID: 87255
    [No Abstract]   [Full Text] [Related]  

  • 7. Human chorionic gonadotropin in seminoma.
    Javadpour N
    J Urol; 1984 Feb; 131(2):407. PubMed ID: 6199523
    [No Abstract]   [Full Text] [Related]  

  • 8. Tumour markers in testicular tumours.
    Chisholm GD
    Prog Clin Biol Res; 1985; 203():81-91. PubMed ID: 2421346
    [No Abstract]   [Full Text] [Related]  

  • 9. Current concepts in management of testicular tumor.
    Javadpour N
    Urol Surv; 1978 Jun; 28(3):89-94. PubMed ID: 80873
    [No Abstract]   [Full Text] [Related]  

  • 10. The value of serum tumor markers in the staging and prognosis of germ cell tumors of the testis.
    Scardino PT; Cox HD; Waldmann TA; Mcintire KR; Mittemeyer B; Javadpour N
    J Urol; 1977 Dec; 118(6):994-9. PubMed ID: 72833
    [No Abstract]   [Full Text] [Related]  

  • 11. Discordant human chorionic gonadotropin results giving rise to inappropriate therapy in a case of testicular cancer.
    Bulger KN; Hesketh PJ; Babayan RK
    J Urol; 1989 Dec; 142(6):1574-5. PubMed ID: 2479778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum alpha-fetoprotein and human chorionic gonadotropin in patients with seminoma.
    Lange PH; Nochomovitz LE; Rosai J; Fraley EE; Kennedy BJ; Bosl G; Brisbane J; Catalona WJ; Cochran JS; Comisarow RH; Cummings KB; deKernion JB; Einhorn LH; Hakala TR; Jewett M; Moore MR; Scardino PT; Streitz JM
    J Urol; 1980 Oct; 124(4):472-8. PubMed ID: 6158584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spermatic cord beta-human chorionic gonadotropin levels in seminoma and their clinical implications.
    Mumperow E; Hartmann M
    J Urol; 1992 Apr; 147(4):1041-3. PubMed ID: 1372658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lactic dehydrogenase in the monitoring and prognosis of testicular cancer.
    Lippert MC; Javadpour N
    Cancer; 1981 Nov; 48(10):2274-8. PubMed ID: 6170417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The current management of advanced testicular cancers.
    Wajsman Z; Murphy GP
    Urol Surv; 1978 Aug; 28(4):127-33. PubMed ID: 81558
    [No Abstract]   [Full Text] [Related]  

  • 16. [Significance of measurement of serum levels of tumor markers with germinal cell testicular tumor--value of beta-subunit human chorionic gonadotropin and alpha-fetoprotein (author's transl)].
    Kamidono S; Arakawa S; Masuda M; Hamami G; Shimatani N; Itho N; Nakatsuka E; Fujii A; Ohono S; Ishigami J; Yoshimoto Y; Hattori M; Fujita T; Okada S
    Nihon Hinyokika Gakkai Zasshi; 1980 Apr; 71(4):352-62. PubMed ID: 6157042
    [No Abstract]   [Full Text] [Related]  

  • 17. [Biological markers and germinal tumors of the testis. Value and limitations of the assay of chorionic gonadotrophin hormone and alpha-fetoprotein].
    Bassoulet J; Pabot du Chatelard P; Ricordel I; Auberget JL; Guillemot MC; Merrer J; Timbal Y
    J Urol (Paris); 1988; 94(8):393-6. PubMed ID: 2467947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Biological markers in testicular cancer].
    Glait HM; Carugati A; Scorticati C; Koss A; Bellora O; Mickiewicz E; Arturi J; Olivari AJ
    Medicina (B Aires); 1982; 42(5):488-94. PubMed ID: 6188940
    [No Abstract]   [Full Text] [Related]  

  • 19. Current management of testicular tumors.
    Catalona WJ
    Surg Clin North Am; 1982 Dec; 62(6):1119-27. PubMed ID: 6184788
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum alpha-fetoprotein and human chorionic gonadotropin in the management of testicular tumors.
    Lange PH
    Natl Cancer Inst Monogr; 1978 Dec; (49):215-7. PubMed ID: 86163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.